Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels
| Autor: | Sun, Lova, Handorf, Elizabeth A., Zhou, Yunyun, Borghaei, Hossein, Aggarwal, Charu, Bauman, Jessica |
|---|---|
| Zdroj: | In Lung Cancer April 2024 190 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect